- Supported exchanges /
- AU /
- DXB.AU
Dimerix Ltd (DXB AU) stock market data APIs
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.
Dimerix Ltd Financial Data Overview
0.38 | |
0.38 | |
- | |
0.385 | |
0.37 | |
0.061-0.665 | |
214 M | |
557 M | |
583 K | |
0.533 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Dimerix Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 583 K
- EBITDA -17 068 810
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Dimerix Ltd Earnings via APIs
- Latest Release 2024-08-29
- EPS/Forecast NaN
Get Dimerix Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: